Virginia Beach, VA, United States of America

Kelly I Guthrie

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 75(Granted Patents)


Location History:

  • Graham, NC (US) (2001 - 2003)
  • Virginia Beach, VA (US) (2003 - 2007)

Company Filing History:


Years Active: 2001-2007

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kelly I Guthrie: Innovator in Viral Fusion Inhibitor Peptides

Introduction

Kelly I Guthrie is a prominent inventor based in Virginia Beach, VA (US). She has made significant contributions to the field of biotechnology, particularly in the development of viral fusion inhibitor peptides. With a total of five patents to her name, her work focuses on enhancing the pharmacokinetic properties of therapeutic peptides.

Latest Patents

Among her latest patents is a groundbreaking invention related to DNA encoding T-1249 and other viral fusion inhibitor peptides useful for treating AIDS. This invention involves enhancer peptide sequences derived from various retroviral envelope (gp41) protein sequences. These sequences enhance the pharmacokinetic properties of any core polypeptide to which they are linked. The discovery that hybrid polypeptides comprising these enhancer peptide sequences linked to a core polypeptide possess enhanced pharmacokinetic properties, such as increased half-life, is a significant advancement. Furthermore, the invention outlines methods for enhancing the pharmacokinetic properties of core polypeptides through the linkage of enhancer peptide sequences.

Career Highlights

Kelly I Guthrie is currently associated with Trimeris, Inc., where she continues to innovate in her field. Her work has been instrumental in developing therapeutic solutions that can potentially improve patient outcomes in the treatment of viral infections.

Collaborations

She collaborates with notable colleagues, including Shawn Barney and Gene Merutka, who contribute to her research and development efforts.

Conclusion

Kelly I Guthrie's contributions to the field of biotechnology, particularly in the area of viral fusion inhibitors, highlight her role as a leading inventor. Her innovative work continues to pave the way for advancements in therapeutic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…